17-74356689-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080466.2(BTBD17):c.1405G>A(p.Val469Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000572 in 1,572,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. V469V) has been classified as Likely benign.
Frequency
Consequence
NM_001080466.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTBD17 | NM_001080466.2 | c.1405G>A | p.Val469Ile | missense_variant | Exon 3 of 3 | ENST00000375366.4 | NP_001073935.1 | |
BTBD17 | XM_011524791.3 | c.1408G>A | p.Val470Ile | missense_variant | Exon 5 of 5 | XP_011523093.1 | ||
BTBD17 | XM_017024622.2 | c.1408G>A | p.Val470Ile | missense_variant | Exon 5 of 5 | XP_016880111.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000137 AC: 3AN: 218916Hom.: 0 AF XY: 0.00000839 AC XY: 1AN XY: 119144
GnomAD4 exome AF: 0.00000493 AC: 7AN: 1420292Hom.: 0 Cov.: 32 AF XY: 0.00000284 AC XY: 2AN XY: 704394
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1405G>A (p.V469I) alteration is located in exon 3 (coding exon 3) of the BTBD17 gene. This alteration results from a G to A substitution at nucleotide position 1405, causing the valine (V) at amino acid position 469 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at